Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Terveystalo has signed an agreement for a EUR 100 million domestic commercial paper program

Terveystalo Plc, Stock Exchange Release, 10 February 2022 at 09:02 am EET   Terveystalo has signed an agreement for a EUR 100 million domestic commercial paper program. Under the program, the company may issue commercial papers with a maturity of less than one year.   The financing arrangement diversifies Terveystalo’ s financing base and supports the Group's normal working capital financing.   OP Corporate Bank Plc is the organizing bank for the commercial paper program.     For more information, please contact: Liisa-Maija Seppänen, Investor Relations Manager

Alzinova receives approximately SEK 2,8 million through the exercise of the warrants of series TO2 2020/2022

In October 2020, Alzinova AB (publ) (“Alzinova” or the “Company”) carried out an issue of units with pre-emption rights for the shareholders (the “Rights Issue”), as well as an issue of units without pre-emption rights for the shareholders to the guarantors in the Rights Issue for their guaranteed commitments (the “Directed Issue”). The units issued in the Rights Issue and the Directed Issue consisted of shares and warrants of series TO2 2020/2022 (the “warrants”). The exercise period for the warrants ran from and including January 24, 2022 up to and including February 7, 2022. In total, 867

Proposals of Terveystalo’s Board of Directors to the Annual General Meeting 2022

Terveystalo Plc Stock Exchange Release 10 February 2022 at 9:01 EET Terveystalo Plc's Board of Directors has decided to propose to the Annual General Meeting to be held on 7 April 2022 that a total dividend of EUR 0.28 per share be paid for 2021. The Board of Directors proposes that the dividend is paid in two instalments. The Board further proposes the adoption of the financial statements, approval of the amended Remuneration Policy and the Remuneration Report for the Company's Governing Bodies, authorizing the Board to decide on the repurchase and/or on the acceptance as pledge of the

First Camp comes to Norway

Scandinavia's largest camping chain, First Camp, has now acquired its first site in Norway. The chain already has 58 destinations in Sweden and Denmark, and has now acquired Norsjø Ferieland in Telemark, in southwestern Norway.First Camp has developed a strong relationship with Norway through the tens of thousands of Norwegian campers who visit First Camp's Swedish and Danish destinations each year. The company’s primary owner, Norvestor, is also based in Norway. Now the chain has acquired its first Norwegian destination. “We have been looking at the Norwegian market for some time, so it'

INVITATION: Finnair Q4 and FY 2021 result – Press conference / webcast and analyst webcast

Finnair will hold a Q4 and FY 2021 financial result press conference (in Finnish) on 17 February 2022 at 11:00 a.m. EET at its headquarters at Tietotie 9. It is also possible to participate in the press conference via a live webcast at https://finnairgroup.videosync.fi/2022-0217-press.    An English-language telephone conference and webcast will be held on 17 February 2022 at 1:00 p.m. EET. The conference may be attended by dialing your local access number +358 (0)9 8171 0310 (Finland), 08 5664 2651 (Sweden), 033 3300 0804 (UK) or +44 (0)33 3300 0804 (all other countries). The

AZN: Full year and Q4 2021 results

AstraZeneca PLC 10 February 2022 07:00 GMT Full year and Q4 2021 results Total Revenue increased by 41% and Core EPS by 32% in a year of exceptional pipeline and commercial delivery, coupled with accelerated strategic transformation through the acquisition of Alexion · Total Revenue increased 41% (38% at CER[1]) to $37,417m including COVID-19 vaccine revenues. Total Revenue excluding vaccine increased 26% (23% at CER) to $33,436m. In Q4 2021, Total Revenue increased 62% (63% CER) to $12,011m · Reported[2] EPS[3] of $0.08 (FY 2020: $2.44) and Core[4] EPS of $5.29 (FY 2020: $4.

Humana reports fourth quarter and full year 2021 results

Temporarily weaker result in the fourth quarter rounded off a stable 2021Fourth quarter, October–December 2021 · Operating revenue was SEK 2,110 million (1,948), an increase of 8 percent. Organic growth was 3.4 percent. · Operating profit amounted to SEK 82m (101), a decline of 18 percent. Adjusted operating profit was SEK 85m (101), a decline of 16 percent. · Net profit after tax for the period amounted to SEK 33m (49). · Basic and diluted earnings per share for the period amounted to SEK 0.68 (0.94). · Operating cash flow amounted to SEK 157m (296). Full year, January–

Essity recognized by CDP for its supplier engagement in fight against climate change

The hygiene and health company Essity has been recognized as Supplier Engagement Leader by the global non-profit environmental organization CDP. The award addresses how Essity successfully has worked with its suppliers in the fight against climate change.Supplier Engagement Leaders are companies at the forefront of efforts to reduce emissions of what is referred to as Scope 3 (which includes purchased goods and services, purchased transportation and waste from operations) in the Science Based Targets initiative. “Our day-to-day activities of governance, targets and Scope 3 reporting is

Attendo year-end and Q4 report 2021: Increased occupancy in challenging period

Attendo shows continued good organic growth during the fourth quarter as well as for the full year 2021. The quarter is negatively impacted by effects from the pandemic, where the combination of high sickness absence during the spread of omicron and lower public compensation affects the result. In the Finnish market, there is a strained personnel situation in the labour market, which is partly offset by price adjustments for renegotiated contracts. The demand for nursing home beds in Swedish has normalized and thanks to strong sales, we managed, despite many newly opened beds, to increase

Fractal Gaming Group Year-end report, Q4 2021

Fourth quarter 2021 · Net sales amounted to SEK 120.7 million (113.9). · Product profit amounted to SEK 39.5 million (33.8), with a product margin of 32.7% (29.7). · Adjusted EBITDA amounted to SEK 2.5 million (7.7), corresponding to an adjusted EBITDA margin of 2.1% (6.8). · Adjusted EBIT amounted to SEK -1.6 million (4.7), with an adjusted EBIT margin of -1.4% (4.1). · Operating cash flow amounted to SEK -11.6 million (-55.6). · Interest-bearing net debt was SEK 126.2 million (49.7). · Earnings per share amounted to SEK -0.1 (-0.1) January-December 2021 ·

Subscription to Kappahl clothes now available via Hack Your Closet

It is now possible to subscribe to selected sections of Kappahl’s brands via the clothing rental service Hack Your Closet. The new collaborative initiative is part of Kappahl’s strategy to make its clothing more widely available and to extend the life of its apparel, and is a step towards reducing the company’s environmental impacts. Selected sections of Kappahl’s popular kay/day and Kappahl Woman brands are now also available to subscribers to Hack Your Closet.      “Fashion is personal and should be fun! We’ve teamed up with Hack Your Closet to bring our products to a wider

Ework Group AB (publ) publishes Year-End Report, January – December 2021: Best Q4 and full-year results so far

“Ework finished the year 2021 with yet another record quarter with higher net sales, higher EBIT and more consultants on assignment than ever before. Ework has strengthened its position on the market and demand for consultancy services remains high. The timing is favourable for me to take over the role as CEO and I look forward to leading Ework’s continued development.” From Karin Schreil’s CEO-statementFourth quarter 2021 compared to 2020 · Net sales increased by 19 percent to SEK 3,862 M (3,238). The increase is due to a significant increase in customer demand and successful sales

Invitation to the Annual General Meeting

Neste Corporation, Stock Exchange Release, 10 February 2022, 09:00 a.m. (EET) The Annual General Meeting (the “AGM”) of Neste Corporation (the “Company”) will be held on Wednesday, 30 March 2022 at 12 noon EET. The AGM will be held under special arrangements without shareholders’ or their proxy representatives’ presence at Company's headquarters at the address Keilaranta 21, 02150 Espoo. The Board of Directors of the Company has resolved on an exceptional meeting procedure based on the Act temporarily amending the Companies Act and certain other community laws (375/2021, the “

Alimak Group: Interim Report January – December 2021

Delivering margin improvements · Significant profit improvement and strong cash flow in line with New Heights Programme · Solid quarter for Industrial, Construction and BMU · Organic revenue growth of 7% · Strategic review of the Wind division to explore future strategic alternatives, including a potential divestmentFourth quarter 2021 · Order intake increased by 8% to MSEK 912 (844) with an organic increase of 5% · Strong service order intake growth organically 14%. · Revenue increased by 10% to MSEK 1,028 (933) with an organic increase of 7%. Strong growth in

Invitation to Q4 Earnings Teleconference

Karnov Group (Nasdaq: KAR) will publish its financial report for the fourth quarter and the financial year 2021 on 23 February at around 08.00 a.m. CET and Management will host a webcasted telephone conference the same day at 10.00 a.m. CET.Karnov Group’s year-end report for the period January – December 2021 will be published on Wednesday 23 February 2022 at around 8.00 a.m. CET. A webcasted telephone conference will be held at 10.00 a.m. CET the same day, where CEO Pontus Bodelsson and CFO Dora Brink Clausen will present the report and answer questions. You can follow the presentation

Year-end report 2021

Strong cloud services revenues and good demand despite delivery delaysOctober - December 2021 · Revenues decreased by 4 percent to SEK 942 (982) million. · Adjusted EBITA decreased by 14 percent and amounted to SEK 56.9 (66.4) million, corresponding to an adjusted EBITA margin of 6.0 (6.8) percent. Items affecting comparability in the fourth quarter amounted to SEK –5.8 (–2.8) million attributable to acquisition related costs. · Profit before tax amounted to SEK 37.4 (50.8) million. · Profit after tax amounted to SEK 31.0 (40.1) million. · Profit per share amounted to SEK 1.

SBB carries out Sweden's largest certification with Miljöbyggnad iDrift (Environmental Building In Use)

Miljöbyggnad iDrift is an important tool in Sweden's work to create sustainable property management of existing properties. Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) certifies 500 of its existing buildings and then certifies another 500. These are a number of different properties such as schools, rent regulated residentials and community service properties around the country. One of Sweden's challenges to achieve the climate goals is to renovate and adapt the sustainability of our existing property portfolio, as 90 percent of the buildings will still be in use in 2050.

Year-end report for January – December 2021

Challenging fourth quarter, continued positive market outlookFinancial development Q4 2021 (October-December) · Net sales decreased by 22% to SEK 200.7 million (257.7). Previously communicated delivery delays due to current component shortages have had a negative impact on the company's net sales. The estimation is that net sales of approximately SEK 50 million have been postponed until 2022 due to shifts in planned deliveries. · Gross margin amounted to 46% (49). · Adjusted EBITDA amounted to SEK 34.6 million (87.5), equivalent to an adjusted operating margin of 17.2% (34.0).

Sobi publishes Q4 and FY 2021 report

Swedish Orphan Biovitrum AB (publ)  (Sobi®) today announces its results for the fourth quarter and full year of 2021. October – December 2021 · Total revenue SEK 4,896 M (4,581), +7 per cent, +9 per cent at constant exchange rates (CER) · Haematology revenue SEK 2,242 M (2,081), +8 per cent at CER of which Elocta® SEK 1,063 M (1,071), unchanged at CER, Alprolix® SEK 482 M (419), +16 per cent at CER, and Doptelet® SEK 306 M (191), +60 per cent at CER. First shipment of Empaveli™ achieved · Immunology revenue SEK 2,330 M (2,281), +6 per cent at CER of which

Terveystalo Group Financial Statement Bulletin 2021: Record year – Growing as a stronger company

Terveystalo Plc, Financial Statement Bulletin 10 February, 2022 at 09:00 EET    This release is a summary of Terveystalo's Financial Statement Bulletin 2021. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/   October–December 2021 in brief •          Revenue increased by 17.1% year-on-year to EUR 327.5 (279.7) million. •          Adjusted1) earnings before interest, taxes, and amortization (EBITA) increased by 6.6% to EUR 41.9 (39.3) million,

Olvi Group’s Financial Statements January to December 2021

OLVI PLC                  Financial Statements Bulletin 10 Feb 2022 at 9:00 am Olvi Group’s Financial Statements January to December 2021 Financial performance in brief Olvi Group’s sales volume, net sales and operating profit for 2021 made all-time highs for the sixth year in a row. The Group’s financial standing remained on a good level. The Board proposes a dividend of 1.20 (1.10) euro per share.   Near-term outlook   Olvi’s operating profit for fiscal year 2022 is expected to remain on the previous year’s good level.   Sales volume and net sales are expected

Neste's Financial Statements Release for 2021

Neste Corporation, Financial Statements Release, 10 February 2022 at 9 a.m. (EET) Excellent performance in a year of major scheduled maintenance shutdowns and high input costs Year 2021 in brief: · Comparable EBITDA totaled EUR 1,920 million (EUR 1,929 million) · EBITDA totaled EUR 2,607 million (EUR 1,508 million) · Comparable operating profit totaled EUR 1,342 million (EUR 1,416 million) · Operating profit totaled EUR 2,023 million (EUR 828 million) · Cash flow before financing activities totaled EUR 511 million (EUR 1,019 million) · Return on average capital

Metso Outotec’s Financial Statements Review January 1 – December 31, 2021

Metso Outotec Corporation’s stock exchange release on February 10, 2022, at 09:00 a.m. EETThe merger of Metso Minerals and Outotec was completed on June 30, 2020. The comparative financial information for January-June 2020, prior to the merger, is based on the illustrative combined historical Metso Minerals carve-out information and Outotec information. Figures in brackets refer to the corresponding period in 2020, unless otherwise stated. Fourth-quarter 2021 in brief, IFRS · Strong market activity continued · Orders received totaled EUR 1,310 million (EUR 1,304 million) ·

Teleste establishes a new share-based long-term incentive program

TELESTE CORPORATION                           STOCK EXCHANGE RELEASE                                         10 FEBRUARY 2022 AT 09:00 EET TELESTE ESTABLISHES A NEW SHARE-BASED LONG-TERM INCENTIVE PROGRAM The Board of Directors of Teleste Corporation has decided to establish a new share-based program that includes three new share-based incentive plans (LTI 2022 Program) for the key employees of Teleste. The objective of LTI 2022 Program is to align the interests of the key employees and Teleste shareholders by creating a long-term equity interest for the key employees and, thus, to

There are no items matching the current filter
There are no more items matching the current filter
Back to top